ワシントンにおける脳腫瘍の臨床試験
ワシントン内の拠点で、脳腫瘍に関する12件の研究が参加者を募集しています。
ワシントン内の都市
公式研究テキスト（英語）
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- Northwest Medical Specialties, Tacoma
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/24更新 · NCT06047379Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Fred Hutchinson Cancer Research Center, Seattle
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/16更新 · NCT05786924A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
- Local Institution - 0086, Seattle
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/16更新 · NCT07492680A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- Providence Regional Cancer System-Aberdeen, Aberdeen
- PeaceHealth Saint Joseph Medical Center, Bellingham
- Providence Regional Cancer System-Centralia, Centralia
- 他15件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/15更新 · NCT04511013A Phase 1/1b Study of IAM1363 in HER2 Cancers
- Fred Hutchinson Cancer Center, Seattle
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/09更新 · NCT06253871Targeted Pediatric High-Grade Glioma Therapy
- Seattle Children's Hospital, Seattle
被験者募集中観察研究
12 Months – 39 Years · 全性別 · 2026/09/08更新 · NCT05839379Study of Olutasidenib and Temozolomide in HGG
- Seattle Children's Hospital, Seattle
被験者募集中第2相
12歳〜39歳 · 全性別 · 2026/09/01更新 · NCT06161974Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
- Seattle Children's Hospital, Seattle
被験者募集中第2相
1歳〜26歳 · 全性別 · 2026/08/04更新 · NCT07680439Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
- Virginia Mason, Seattle
被験者募集中観察研究
全年齢 · 全性別 · 2026/07/22更新 · NCT04427384Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Seattle Children's Hospital, Seattle
被験者募集中第2相
12 Months – 39 Years · 全性別 · 2026/05/29更新 · NCT05843253Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
- Seattle Children's Hospital, Seattle
被験者募集中第1相
1歳〜26歳 · 全性別 · 2026/04/13更新 · NCT04185038S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- PeaceHealth Saint Joseph Medical Center, Bellingham
- Swedish Cancer Institute-Issaquah, Issaquah
- FHCC South Lake Union, Seattle
- 他2件
被験者募集中第3相
18歳以上 · 全性別 · 2025/10/08更新 · NCT03418961ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。